| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study
|
Ishida, Takashi
|
|
|
120 |
8 |
p. 1734-1741
|
article
|
| 2 |
Allogeneic HSCT for ATL: a good start
|
Abboud, Camille
|
|
|
120 |
8 |
p. 1541-1542
|
article
|
| 3 |
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
|
Iland, Harry J.
|
|
|
120 |
8 |
p. 1570-1580
|
article
|
| 4 |
ATRA plus arsenic gets another “A” in APL
|
Park, Jae H.
|
|
|
120 |
8 |
p. 1535-1536
|
article
|
| 5 |
Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α
|
Valéra, Marie-Cécile
|
|
|
120 |
8 |
p. 1703-1712
|
article
|
| 6 |
Continuing Medical Education (CME) questions: all-trans-retinoic acid, idarubicin, and arsenic therapy for APL
|
|
|
|
120 |
8 |
p. 1752
|
article
|
| 7 |
Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7
|
Zangi, Lior
|
|
|
120 |
8 |
p. 1647-1657
|
article
|
| 8 |
Does size matter in platelet production?
|
Thon, Jonathan N.
|
|
|
120 |
8 |
p. 1552-1561
|
article
|
| 9 |
Economics of hematopoietic cell transplantation
|
Khera, Nandita
|
|
|
120 |
8 |
p. 1545-1551
|
article
|
| 10 |
Editorial Board
|
|
|
|
120 |
8 |
p. i
|
article
|
| 11 |
Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes
|
Kim, Dong Seok
|
|
|
120 |
8 |
p. 1658-1667
|
article
|
| 12 |
Full reconstitution of human platelets in humanized mice after macrophage depletion
|
Hu, Zheng
|
|
|
120 |
8 |
p. 1713-1716
|
article
|
| 13 |
How I manage venous thromboembolism risk in hospitalized medical patients
|
Dobromirski, Mark
|
|
|
120 |
8 |
p. 1562-1569
|
article
|
| 14 |
Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice
|
Axelsson, Jakob
|
|
|
120 |
8 |
p. 1742-1751
|
article
|
| 15 |
Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A
|
Pulvino, Mary
|
|
|
120 |
8 |
p. 1668-1677
|
article
|
| 16 |
Intrinsic impairment of CD4+CD25+ regulatory T cells in acquired aplastic anemia
|
Shi, Jun
|
|
|
120 |
8 |
p. 1624-1632
|
article
|
| 17 |
LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas
|
Zhang, Yong
|
|
|
120 |
8 |
p. 1678-1686
|
article
|
| 18 |
Lymphocytosis: T-cell large granular lymphocyte leukemia
|
Munoz, Javier
|
|
|
120 |
8 |
p. 1543
|
article
|
| 19 |
Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias
|
Doubrovina, Ekaterina
|
|
|
120 |
8 |
p. 1633-1646
|
article
|
| 20 |
Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells
|
Asai, Takashi
|
|
|
120 |
8 |
p. 1601-1612
|
article
|
| 21 |
Posttranslational regulation of self-renewal capacity: insights from proteome and phosphoproteome analyses of stem cell leukemia
|
Trost, Matthias
|
|
|
120 |
8 |
p. e17-e27
|
article
|
| 22 |
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group
|
Loken, Michael R.
|
|
|
120 |
8 |
p. 1581-1588
|
article
|
| 23 |
Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance
|
Usmani, Saad Z.
|
|
|
120 |
8 |
p. 1597-1600
|
article
|
| 24 |
Second to none
|
Rajkumar, S. Vincent
|
|
|
120 |
8 |
p. 1537-1539
|
article
|
| 25 |
Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans
|
Coombs, Catherine C.
|
|
|
120 |
8 |
p. 1687-1690
|
article
|
| 26 |
SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control
|
Reddy, Pavankumar N.G.
|
|
|
120 |
8 |
p. 1691-1702
|
article
|
| 27 |
Structural basis for catalytic activation of protein Z–dependent protease inhibitor (ZPI) by protein Z
|
Huang, Xin
|
|
|
120 |
8 |
p. 1726-1733
|
article
|
| 28 |
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
|
Rosiñol, Laura
|
|
|
120 |
8 |
p. 1589-1596
|
article
|
| 29 |
TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas
|
Weng, Jinsheng
|
|
|
120 |
8 |
p. 1613-1623
|
article
|
| 30 |
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway
|
Krisinger, Michael J.
|
|
|
120 |
8 |
p. 1717-1725
|
article
|
| 31 |
Toward an off-the-shelf vaccine for B-cell malignancies
|
Gulley, James L.
|
|
|
120 |
8 |
p. 1539-1540
|
article
|
| 32 |
What T cells see in WT-1
|
Molldrem, Jeffrey J.
|
|
|
120 |
8 |
p. 1540-1541
|
article
|
| 33 |
When it comes to MRD, AML ≠ ALL
|
Paietta, Elisabeth
|
|
|
120 |
8 |
p. 1536-1537
|
article
|
Journal description